Ji Youl Lee Selected Research

Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)

4/2020	The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction.
12/2015	Changes in Nocturia and Lower Urinary Tract Symptoms after Radical Prostatectomy.
3/2014	Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study.
11/2006	When to use antimuscarinics in men who have lower urinary tract symptoms.
10/2004	Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji Youl Lee Research Topics

Disease

57	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 07/2009
24	Neoplasms (Cancer) 05/2024 - 11/2004
22	Erectile Dysfunction 02/2024 - 12/2011
12	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2023 - 01/2011
10	Lower Urinary Tract Symptoms 01/2018 - 11/2006
9	Overactive Urinary Bladder (Overactive Bladder) 04/2020 - 05/2002
8	Carcinoma (Carcinomatosis) 09/2023 - 07/2009
7	Prostatitis 02/2024 - 06/2002
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 11/2004
7	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2018
7	Urinary Incontinence 04/2020 - 03/2006
5	Pain (Aches) 10/2022 - 07/2011
5	Fibrosis (Cirrhosis) 01/2021 - 01/2006
5	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 04/2020 - 10/2004
5	Carcinogenesis 01/2018 - 08/2009
4	Pelvic Pain 02/2024 - 01/2019
4	Diabetes Mellitus 06/2021 - 11/2018
4	Hyperplasia 04/2020 - 03/2013
4	Nocturia 01/2018 - 02/2013
4	Urinary Retention 01/2013 - 10/2004
3	Inflammation (Inflammations) 02/2024 - 01/2019
3	Exanthema (Rash) 01/2021 - 04/2018
3	Ganglion Cysts (Ganglion) 01/2021 - 10/2012
3	Atrophy 12/2017 - 01/2013
3	Body Weight (Weight, Body) 01/2014 - 04/2013
3	Stress Urinary Incontinence 02/2013 - 06/2011
2	Fatigue 04/2024 - 01/2020
2	Hyperthermia 02/2024 - 07/2020
2	Chronic Renal Insufficiency 09/2023 - 05/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2022 - 01/2016
2	Flatulence 01/2021 - 01/2020
2	Postoperative Pain 04/2018 - 12/2014
2	Infertility (Sterility) 01/2016 - 10/2014
2	Male Infertility (Male Sterility) 01/2016 - 10/2014
2	Cryptorchidism (Undescended Testes) 01/2016 - 10/2014
2	Kidney Calculi (Kidney Stone) 08/2014 - 08/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2014 - 04/2013
2	Lacerations 08/2013 - 01/2006
2	Edema (Dropsy) 01/2013 - 07/2011

Drug/Important Bio-Agent (IBA)

11	Prostate-Specific Antigen (Semenogelase)IBA 05/2024 - 10/2011
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
8	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2016
7	AndrogensIBA 01/2021 - 01/2014
7	HydrogelsIBA 12/2018 - 07/2011
5	apalutamideIBA 12/2023 - 04/2018
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2020 - 03/2011
5	AntioxidantsIBA 04/2020 - 11/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021 - 03/2011
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 10/2012
4	salicylhydroxamic acid (SHAM)IBA 07/2020 - 08/2013
4	ZincIBA 11/2012 - 06/2002
3	CytokinesIBA 02/2024 - 08/2016
3	Toll-Like Receptor 4IBA 02/2024 - 04/2012
3	Therapeutic UsesIBA 02/2024 - 01/2006
3	MicroRNAs (MicroRNA)IBA 06/2021 - 04/2010
3	Streptozocin (Streptozotocin)FDA Link 06/2021 - 07/2016
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2014 - 03/2011
3	Cholinergic Antagonists (Anticholinergics)IBA 03/2014 - 08/2012
3	Tolterodine Tartrate (Detrol)FDA Link 01/2013 - 05/2002
2	Capsules (Microcapsules)IBA 05/2024 - 05/2023
2	HMGB1 Protein (HMG1)IBA 02/2024 - 01/2021
2	AntigensIBA 02/2024 - 03/2023
2	RadiopharmaceuticalsIBA 02/2024 - 12/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 04/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
2	Testosterone (Sustanon)FDA Link 03/2021 - 08/2015
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2021 - 09/2014
2	PlatinumIBA 01/2021 - 10/2020
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2021 - 04/2020
2	NF-kappa B (NF-kB)IBA 07/2020 - 08/2009
2	Dihydrotestosterone (Androstanolone)IBA 07/2020 - 01/2019
2	LipopolysaccharidesIBA 07/2020 - 01/2019
2	enzalutamideIBA 01/2020 - 01/2019
2	Hematoxylin (Haematoxylon)IBA 03/2018 - 01/2006
2	Eosine Yellowish-(YS) (Eosin)IBA 03/2018 - 01/2006
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2018 - 03/2014
2	SuspensionsIBA 12/2016 - 06/2002
2	Analgesics (Analgesic Drugs)IBA 08/2015 - 05/2013
2	Hormones (Hormone)IBA 01/2015 - 06/2012
2	MetalsIBA 01/2015 - 08/2014
2	Ethanol (Ethyl Alcohol)IBA 08/2014 - 04/2013
2	GelatinIBA 06/2014 - 07/2011
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 07/2013 - 02/2013

Therapy/Procedure

34	Therapeutics 02/2024 - 10/2004
25	Prostatectomy (Retropubic Prostatectomy) 05/2024 - 10/2011
17	Castration 04/2024 - 01/2016
9	Extracorporeal Shockwave Therapy 10/2022 - 12/2017
8	Lasers (Laser) 04/2020 - 03/2011
6	Injections 02/2024 - 03/2006
6	Cystectomy 01/2024 - 01/2010
5	Drug Therapy (Chemotherapy) 01/2021 - 11/2004
5	Oral Administration 05/2020 - 07/2011
4	Length of Stay 04/2022 - 12/2014
3	Nephrectomy 09/2023 - 01/2016
3	Aftercare (After-Treatment) 01/2021 - 02/2013
3	Percutaneous Nephrolithotomy 04/2018 - 08/2012
2	Analgesia 04/2022 - 12/2014
2	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2016
2	Radiotherapy 03/2021 - 03/2015
2	Nephrotomy 04/2018 - 11/2011